GlassScriptPhysician profile
Raju Thakor
NPI 1649459942
$6,405.77
in general payments reported to CMS, 2019-2025
16 companies · $189 in 2025
The $189 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $767 · 2020: $115 · 2021: $448 · 2022: $380 · 2023: $116 · 2024: $4,391 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Food and Beverage: $492 · Travel and Lodging: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Food and Beverage | $492.44 |
| Travel and Lodging | $203.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,237.54 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $524.88 | 2020-2023 | Tezspire |
| Glaxosmithkline, LLC. | $476.39 | 2019-2025 | Arexvy, Trelegy Ellipta |
| Broncus Medical | $177.07 | 2019 | |
| Merck Sharp & Dohme LLC | $176.03 | 2019-2025 | Zerbaxa |
| Insmed, INC. | $144.10 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $130.20 | 2022 | |
| La Jolla Pharmaceutical Company | $124.99 | 2019 | |
| Ethicon INC. | $109.58 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.58 | 2025 | Ofev |
| Ekos Corporation | $92.23 | 2019 | |
| United Therapeutics Corporation | $33.80 | 2025 | Tyvaso |
| Grifols USA, LLC | $24.64 | 2025 | Prolastin-C Liquid |
| Regeneron Healthcare Solutions, INC. | $23.73 | 2023 | Dupixent |
| Getinge USA Sales, LLC | $19.00 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raju Thakor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.